Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
926.00    -4.00 (-0.43%)
Bid:
924.00
Ask:
930.00
Spread: 6.00 (0.649%)
Market Cap: £503.84m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate Change

22 Jan 2025 15:48

RNS Number : 3399U
JPMorgan Claverhouse IT PLC
22 January 2025
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Tom Smethers as a Non-Executive Director of the Company with effect from 3rd February 2025.

 

Mr. Smethers is an experienced finance professional, with a strong background in the FMCG, retail, hospitality and aviation sectors. Mr. Smethers has led major transformation projects, handled multiple M&A processes, and has international experience across Europe, the Middle East, and Australia.

Mr. Smethers was previously a Non-Executive Director and Audit Committee Chair of Artemis Alpha Trust plc and is currently a trustee of the charity, Wings for Warriors. He is presently the Chief Financial Officer at Carlsberg Britvic plc and held senior positions at Costa Coffee, TUI Group, Jumeirah Group LLC, and easyJet plc.

 

Mr. Smethers is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

Mr. Smethers does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Smethers.

 

 

22nd January 2025

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDBRSDDGUD
Date   Source Headline
12th Feb 202510:22 amRNSNet Asset Value(s)
11th Feb 202510:10 amRNSNet Asset Value(s)
10th Feb 20255:03 pmRNSTransaction in Own Shares
10th Feb 202511:29 amRNSGearing announcement
10th Feb 202510:56 amRNSNet Asset Value(s)
7th Feb 20255:07 pmRNSTransaction in Own Shares
7th Feb 202511:09 amRNSNet Asset Value(s)
6th Feb 202510:48 amRNSNet Asset Value(s)
5th Feb 20254:58 pmRNSTransaction in Own Shares
5th Feb 202510:22 amRNSNet Asset Value(s)
4th Feb 20254:59 pmRNSTransaction in Own Shares
4th Feb 202511:21 amRNSNet Asset Value(s)
3rd Feb 202512:41 pmRNSGearing Announcement
3rd Feb 202511:25 amRNSNet Asset Value(s)
3rd Feb 20259:48 amRNSTotal Voting Rights
31st Jan 20254:57 pmRNSTransaction in Own Shares
31st Jan 202510:16 amRNSNet Asset Value(s)
30th Jan 20255:24 pmRNSTransaction in Own Shares
30th Jan 202510:23 amRNSNet Asset Value(s)
29th Jan 20255:10 pmRNSTransaction in Own Shares
29th Jan 202510:33 amRNSNet Asset Value(s)
28th Jan 20255:05 pmRNSTransaction in Own Shares
28th Jan 202510:51 amRNSNet Asset Value(s)
27th Jan 20255:06 pmRNSTransaction in Own Shares
27th Jan 202511:38 amRNSGearing announcement
27th Jan 202510:30 amRNSNet Asset Value(s)
24th Jan 20254:53 pmRNSTransaction in Own Shares
24th Jan 202510:22 amRNSNet Asset Value(s)
23rd Jan 202510:51 amRNSNet Asset Value(s)
22nd Jan 20254:02 pmRNSFourth Quarterly Interim Dividend Declaration
22nd Jan 20253:48 pmRNSDirectorate Change
22nd Jan 202510:44 amRNSNet Asset Value(s)
21st Jan 20254:48 pmRNSTransaction in Own Shares
21st Jan 202510:39 amRNSNet Asset Value(s)
20th Jan 202512:11 pmRNSGearing announcement
20th Jan 202511:28 amRNSNet Asset Value(s)
17th Jan 20255:02 pmRNSTransaction in Own Shares
17th Jan 202510:40 amRNSNet Asset Value(s)
16th Jan 202510:26 amRNSNet Asset Value(s)
15th Jan 20255:34 pmRNSTransaction in Own Shares
15th Jan 202510:20 amRNSNet Asset Value(s)
14th Jan 202510:49 amRNSNet Asset Value(s)
13th Jan 202511:53 amRNSGearing announcement
13th Jan 202510:41 amRNSNet Asset Value(s)
10th Jan 202511:16 amRNSNet Asset Value(s)
10th Jan 20259:48 amRNSTen Largest Investments
9th Jan 202510:49 amRNSNet Asset Value(s)
8th Jan 202510:48 amRNSNet Asset Value(s)
7th Jan 202510:46 amRNSNet Asset Value(s)
6th Jan 202512:07 pmRNSGearing announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.